Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis

BACKGROUND: The surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal squamous cell carcinoma (ESCC) remains unelucidated. This study aimed to determine the validity of PFS as a surrogate endpoint for OS in ESCC patients treated with definitive radiotherapy or definiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Weiming, Wang, Lan, Li, Chen, Chen, Junqiang, Zhang, Wencheng, Wang, Xin, Pang, Qingsong, Zhao, Yidian, Sun, Xinchen, Zhang, Kaixian, Li, Gaofeng, Li, Ling, Qiao, Xueying, Liu, Miaoling, Wang, Yadi, Deng, Lei, Wang, Wenqing, Bi, Nan, Zhang, Tao, Deng, Wei, Ni, Wenjie, Chang, Xiao, Zhou, Zongmei, Liang, Jun, Feng, Qinfu, Wang, Lvhua, Chen, Dongfu, Lv, Jima, Zhu, Shuchai, Han, Chun, Xiao, Zefen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619262/
https://www.ncbi.nlm.nih.gov/pubmed/36324733
http://dx.doi.org/10.1177/17588359221131526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619262/
https://www.ncbi.nlm.nih.gov/pubmed/36324733
http://dx.doi.org/10.1177/17588359221131526

Ejemplares similares